Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	17.03	21.03	5.38	8.49	11.78	24.06
Cash & Short-Term Investments	17.03	21.03	5.38	8.49	11.78	24.06
Cash Growth	28.27%	290.77%	-36.61%	-27.93%	-51.03%	68.89%
Other Current Assets	0.37	0.45	0.35	0.83	0.67	0.67
Total Current Assets	17.4	21.48	5.74	9.32	12.45	24.73
Net Property, Plant & Equipment	0.01	0.01	0	0.04	0.34	0.42
Other Long-Term Assets	-	-	-	0	0.02	0.03
Total Assets	17.41	21.49	5.74	9.36	12.81	25.17
Accounts Payable	0.26	0.44	0.25	0.66	0.78	0.28
Accrued Expenses	0.69	0.91	0.76	0.94	1.03	2.66
Current Portion of Leases	-	-	-	0.04	0.14	0.13
Total Current Liabilities	0.95	1.34	1.02	1.63	1.94	3.07
Long-Term Leases	-	-	-	-	0.04	0.17
Total Long-Term Liabilities	-	-	-	-	0.04	0.17
Total Liabilities	0.95	1.34	1.02	1.63	1.97	3.24
Common Stock	0	0	0	-	-	0
Additional Paid-in Capital	175.52	175.2	151.08	146.94	139.22	138.83
Retained Earnings	-	-155.05	-146.36	-139.21	-128.38	-116.9
Total Common Shareholders' Equity	175.52	20.15	4.72	7.73	10.84	21.93
Minority Interest	-	-	-	-	0	-
Shareholders' Equity	175.52	20.15	4.72	7.73	10.84	21.93
Total Liabilities & Equity	176.47	21.49	5.74	9.36	12.81	25.17
Total Debt	-	0	0	0.04	0.17	0.3
Net Cash (Debt)	17.03	21.03	5.38	8.46	11.61	23.76
Net Cash Growth	-19.02%	290.77%	-36.34%	-27.18%	-51.14%	74.69%
Net Cash Per Share	2.18	3.52	6.83	36.52	91.94	200.01
Book Value	175.52	20.15	4.72	7.73	10.84	21.93
Book Value Per Share	22.47	3.37	6.00	33.39	85.82	184.61
Tangible Book Value	175.52	20.15	4.72	7.73	10.84	21.93
Tangible Book Value Per Share	22.47	3.37	6.00	33.39	85.82	184.61

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q